PIK3CA and head and neck squamous cell carcinoma: On the other hand, comprehensive elucidation of the molecular mechanisms underlying the anti-HNSCC activity of PI3K inhibitors remain largely undefined, which is fundamental to uncover novel therapeutic strategies to optimize the clinical efficacy.